Ibrutinib Plus Nivolumab in 4 Cohorts of Patients With R/R NHL or CLL

According to results of an exploratory study, patients with Richter transformation may benefit from treatment with ibrutinib plus nivolumab.

from Latest articles from Cancer Therapy Advisor News http://bit.ly/2GJHBom